scispace - formally typeset
J

Joost J. F. P. Luiken

Researcher at Maastricht University

Publications -  161
Citations -  10514

Joost J. F. P. Luiken is an academic researcher from Maastricht University. The author has contributed to research in topics: Fatty acid & CD36. The author has an hindex of 56, co-authored 155 publications receiving 9598 citations.

Papers
More filters
Journal ArticleDOI

Membrane Fatty Acid Transporters as Regulators of Lipid Metabolism: Implications for Metabolic Disease

TL;DR: In this article, it was shown that following an acute stimulus, particularly insulin or muscle contraction, specific fatty acid transporters translocate from intracellular stores to the plasma membrane to facilitate fatty acid uptake.
Journal ArticleDOI

Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36.

TL;DR: FAT/CD36 provides another potential therapeutic target for the prevention and/or treatment of insulin resistance and the increased rate of fatty acid transport may contribute to the increased rates of triacylglycerol accumulation in human skeletal muscle.
Journal ArticleDOI

Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling

TL;DR: It is concluded that AMP kinase regulates cardiac FA use through mobilization of FAT/CD36 from a contraction-inducible intracellular storage compartment.
Journal ArticleDOI

A novel function for fatty acid translocase (FAT)/CD36: involvement in long chain fatty acid transfer into the mitochondria.

TL;DR: A role for FAT/CD36 in mitochondrial long chain fatty acid uptake is suggested and system flexibility is demonstrated to match FAT/ CD36 mitochondrial content with an increased capacity for fatty acid oxidation, possibly involving translocation of FAT/cd36 to the mitochondria.
Journal ArticleDOI

Insulin Stimulates Long-Chain Fatty Acid Utilization by Rat Cardiac Myocytes Through Cellular Redistribution of FAT/CD36

TL;DR: A novel role of insulin in cardiac FA utilization is demonstrated and Malfunctioning of insulin-induced FAT/CD36 translocation may be involved in the development of type 2 diabetic cardiomyopathies.